![](/img/cover-not-exists.png)
Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer
Mark Garzotto, Celestia S. Higano, Catherine O'Brien, Brooks L. S. Rademacher, Nicole Janeba, Ladan Fazli, Paul H. Lange, Stephen Lieberman, Tomasz M. BeerVolume:
116
Year:
2010
Language:
english
Pages:
10
DOI:
10.1002/cncr.24960
File:
PDF, 189 KB
english, 2010